JANUARY 8, 2015
The Keck Center of the National Academies
500 Fifth Street, NW,
Washington, DC 20001
1:00 p.m. | Welcome study sponsors and introductory remarks Jerome F. Strauss III (Committee Chair) Virginia Commonwealth University School of Medicine Lisa Richardson Centers for Disease Control and Prevention Discussion and Q&A |
2:00 p.m. | Invited statements from stakeholders Calaneet Balas Ovarian Cancer National Alliance Comments from other public attendees |
2:30 p.m. | Summary and adjournment of public session |
APRIL 7, 2015
The Keck Center of the National Academies
500 Fifth Street, NW,
Washington, DC 20001
8:45 a.m. | Welcome and opening remarks; introduction of committee Jerome F. Strauss III (Committee Chair) Virginia Commonwealth University School of Medicine |
TOPIC #1: THE BIOLOGY OF OVARIAN CANCER | |
9:00 a.m. | Introductions Douglas A. Levine (Moderator) Memorial Sloan Kettering Cancer Center |
9:05 a.m. | Series of presentations Cell of origin: Stem cells Alexander Nikitin Cornell University Cell of origin: Fallopian tubes Ronny Drapkin University of Pennsylvania Genetics/Single-Nucleotide Polymorphisms Simon Gayther University of Southern California |
9:50 a.m. | Discussion with committee |
TOPIC #2: SCREENING AND EARLY DETECTION | |
10:50 a.m. | Introductions Shelley S. Tworoger (Moderator) Harvard Medical School/Harvard School of Public Health/Brigham and Women’s Hospital |
10:55 a.m. | Series of presentations Risk factors and biomarkers by histologic subtypes Nicolas Wentzensen National Cancer Institute |
Imaging-based diagnostics for early detection Martin McIntosh Fred Hutchinson Cancer Research Center Design of screening trials Christine Berg Johns Hopkins Medicine |
|
11:40 a.m. | Discussion with committee |
TOPIC #3: NOVEL TREATMENTS | |
1:15 p.m. | Introductions Anil K. Sood (Moderator) The University of Texas MD Anderson Cancer Center |
1:20 p.m. | Series of presentations Challenges of development of novel therapeutics in ovarian cancer Tony Ho AstraZeneca Nonpharmacologic approaches Melinda Irwin Yale University Targeting p53 Guillermina Lozano The University of Texas MD Anderson Cancer Center |
2:05 p.m. | Discussion with committee |
TOPIC #4: SURVIVORSHIP | |
3:00 p.m. | Introductions Heidi Donovan (Moderator) University of Pittsburgh School of Nursing |
3:05 p.m. | Series of presentations Biobehavioral pathways in epithelial ovarian cancer Susan Lutgendorf University of Iowa |